1Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
2Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
3Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Copyright © 2014 by the Korean Cancer Association
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
RT, radiotherapy; CT, chemotherapy; DFS, disease free survival; OS, overall survival; BCS, breast conserving surgery; SLNB, sentinel lymph node biopsy; FAC, fluorouracil, doxorubicin, and cyclophosphamide; ALND, axillary lymph node dissection; MRM, modified radical mastectomy; CMF, cyclophosphamide, methotrexate, and 5-fluorouracil; CAP, doxorubicin, cyclophosphamide and cisplatin. + indicates that DFS or OS has not yet been reached and censored.
Patient No. | Age (yr) /Gender |
Menopausal status |
Clinical presentation |
TNM stage | Surgery | Axillary management |
Postoperative RT |
Adjuvant CT |
Local recurrence |
Distant metastasis (sites) |
DFS (mo) |
OS (mo) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 70/F | Postmenopausal | Routine screening | pT2N0M0 | BCS | SLNB | No | No | No | No | 28+ | 28+ |
2 | 33/F | Premenopausal | Palpable mass | pT2N0M0 | BCS | SLNB | Yes | Yes (FAC) | No | Yes (lung) | 32 | 68+ |
3 | 56/F | Postmenopausal | Mass, skin retraction | pT1N0M0 | BCS | ALND | Yes | No | No | No | 65+ | 65+ |
4 | 47/F | Premenopausal | Palpable mass | pT2N0M0 | MRM | SLNB | No | Yes (CMF) | No | No | 48+ | 48+ |
5 | 49/F | Premenopausal | Palpable mass | pT2N0M0 | MRM | ALND | No | Yes (FAC) | Yes | No | 45 | 100+ |
6 | 58/F | Postmenopausal | Palpable mass | pT2N0M0 | MRM | ALND | No | Yes (CAP) | No | Yes (bone, lung, liver) | 75 | 78+ |
RT, radiotherapy; CT, chemotherapy; DFS, disease free survival; OS, overall survival; BCS, breast conserving surgery; SLNB, sentinel lymph node biopsy; FAC, fluorouracil, doxorubicin, and cyclophosphamide; ALND, axillary lymph node dissection; MRM, modified radical mastectomy; CMF, cyclophosphamide, methotrexate, and 5-fluorouracil; CAP, doxorubicin, cyclophosphamide and cisplatin. + indicates that DFS or OS has not yet been reached and censored.